NCT01450176View on ClinicalTrials.gov

Comparing Patient Satisfaction With Pataday or Bepreve

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

December 31, 2011

Conditions
Eye Allergies
Interventions
DRUG

Olopatadine hydrochloride 0.2%

1 drop in each eye once daily for 2 weeks

DRUG

Bepotastine besilate ophthalmic solution 1.5%

1 drop in each eye twice daily for 2 weeks

Trial Locations (1)

37129

McCabe Vision Center, Murfreesboro

Sponsors
All Listed Sponsors
lead

McCabe Vision Center

OTHER